Spondylolysis
11
1
1
5
Key Insights
Highlights
Success Rate
63% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 74/100
27.3%
3 terminated out of 11 trials
62.5%
-24.0% vs benchmark
9%
1 trials in Phase 3/4
60%
3 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (11)
Bone Stimulator for Spondylolysis
Association Of Serum Vitamin D Level With Isthmic Spondylolysis
Rest Before Physical Therapy in Adolescents With Active Spondylolysis and Spondylolisthesis
Effects of Low-intensity Pulsed Ultrasound on Pain and Functional Disability in Patients With Lumbar Spondylolysis
A Prospective Study to Compare Bupivacaine and Exparel Versus Bupivacaine or Exparel Alone for Postoperative Pain Relief
Slotted Hole Versus Fixed Hole C-Tek
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Human Amniotic Tissue-derived Allograft, NuCel, in Posteriolateral Lumbar Fusions for Degenerative Disc Disease
Immune Effect of Dexmedetomidine in Patients Undergoing to Spinal Fusion
The Addition of a Pilates Program for Short-Term Improvements in Patients With Spondylolysis or Spondylolisthesis
Direct Repair Surgery for Spondylolysis of Lumbar in Young Population